A Phase II Trial of Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme.

Trial Profile

A Phase II Trial of Combination Therapy With Thalidomide and CPT-11 in Patients With Recurrent Anaplastic Gliomas or Glioblastoma Multiforme.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2012

At a glance

  • Drugs Irinotecan; Thalidomide
  • Indications Glioblastoma; Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 21 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top